MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. - Wikidata - wikimedia - TriplyDB

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

http://www.wikidata.org/entity/Q34242946

about

Nicotine and pathological angiogenesis The Oncogenic Functions of Nicotinic Acetylcholine Receptors Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors.Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation RNA-Seq Reveals the Angiogenesis Diversity between the Fetal and Adults Bone Mesenchyme Stem Cell.Nicotine and lung cancer.In vitro and ex vivo retina angiogenesis assays.α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.Vagal Modulation of the Inflammatory Response in Sepsis.New molecular insights in tobacco-induced lung cancer.FGF-2 Gene Polymorphism in Osteoporosis among Guangxi's Zhuang Chinese.Expression of acetylcholine receptors by experimental rat renal allografts.Role of the Nervous System in Tumor Angiogenesis.α7 nicotinic acetylcholine receptors in lung cancer.

P2860

Q24606748-B5ED0DF3-FEC1-4B36-8104-8B5C6BD88A87 Q26765286-EEFB10DF-E0D8-4892-9756-745921EC7913 Q26998768-939466F0-46A8-4139-9CA6-CBF71CD424CE Q35051513-C3C79589-E53F-4CEC-81F8-82A5880D5A48 Q35204294-43760DD6-9EC1-4DEE-A39B-C807A3722B7B Q35879417-3C4B51D0-9D09-404A-88B9-73A841956CAF Q35930750-FCD298FA-8581-4FA2-9068-B4BE1DA5FD46 Q36754902-02E9ABDE-5733-47FB-80E7-69DC4533C14A Q38152261-EEB430B2-C034-4B6C-8B4B-7554D0D59EFD Q38696785-2B9419D7-AAAD-4938-A935-DCA6BB626A75 Q38820780-A23B979F-8047-4164-AB8F-C4FB6992765B Q39424261-15205B3D-4E21-43CF-B43F-E14AAF4E9C30 Q41181370-C798B759-1012-4B10-B98E-5E3C03CF9F8F Q42092910-64CC16FC-F213-4E2F-A233-60F9B224227E Q52675438-EC8B6E0D-1999-464F-8A19-1DB74985EA94 Q55638955-39440D47-6CDC-44D9-9DE9-81EB9F6AB50B

P2860

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

http://www.wikidata.org/entity/Q34242946

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@ast

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@en

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@nl

type

label

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@ast

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@en

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@nl

prefLabel

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@ast

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@en

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@nl

P1433

Q34242946-ED2C58B6-07CA-4876-8546-D8709205750F

P1476

Q34242946-BBB37556-4D71-4911-9160-CE3B3C4AD2D2

P2093

Q34242946-0B4DAC4D-7309-456F-95F2-C548055E746A

Q34242946-1068483F-380C-46AC-A6BF-45FD6067D869

Q34242946-2C09C038-8D80-4740-9D35-27A8743F779F

Q34242946-2EC2E2C4-879C-429A-91BF-7A3C00B4B0FE

Q34242946-3F83743B-D8D6-4E95-BD68-7977DBEF9E26

Q34242946-6446AB00-E95E-49EF-84FA-949795508EA1

Q34242946-6B5C7892-9CD2-47DC-86C1-A955B24C84B2

Q34242946-72618FC9-9C35-4383-B4CC-E28FE55FDB71

Q34242946-78A51F8F-0FAF-4DDB-981E-46EB6EBCFB92

Q34242946-79377DA5-1F6D-4029-8D9B-CE3ACD307683

P2860

Q34242946-005FF229-53D3-4452-AEDC-EF88EFE8C5C5

Q34242946-0BF8F14D-B889-49C2-9F16-EBA79D920FA3

Q34242946-0D41DDEA-B697-46CC-AF59-1B46D64C0E65

Q34242946-0F215F53-D1B8-4F3A-986D-7B57D700B53E

Q34242946-0FAABDA0-379A-481A-934F-3B55EAEF5CCD

Q34242946-1465FF6D-E390-4143-9238-CB59C5CF8062

Q34242946-257717E8-BF0E-4F99-A4BE-049232DF09ED

Q34242946-2C53210B-40ED-4BF1-8A54-0A8A33DB05C1

Q34242946-3051F5F2-B9AC-49C8-86E8-397CA0CD294C

Q34242946-32A026C8-F9E6-42BC-BDAF-2D6ADC5B884C

P2888

Q34242946-3945D8E1-9316-41F0-8A06-148F2CE9B476

P304

Q34242946-CE2FBE51-BAD9-48C8-933B-295582F7C2BE

P31

Q34242946-867606DD-15F7-40C4-887E-0F8F58ECED3D

P356

Q34242946-1F5D6607-AD49-47B6-97C6-F8C339F7D171

P433

Q34242946-315D06F5-BE7B-49EE-9A5D-3F25E326E4CC

P478

Q34242946-F34B2FB3-2FD8-4EBA-AC4C-E39A402BBBEF

P577

Q34242946-041EDD9A-70DA-4E1E-9784-6FB2166EB340

P698

Q34242946-B15DBF1D-DB57-41BE-B388-7F412F3CA66B

P356

S10456-011-9246-9

P1433

P1476

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.

@en

P2093

Aaron M Dom

http://www.w3.org/2001/XMLSchema#string

Aileen J Marcelo

http://www.w3.org/2001/XMLSchema#string

Brandon S Shiflett

http://www.w3.org/2001/XMLSchema#string

Clayton M Crabtree

http://www.w3.org/2001/XMLSchema#string

Elsa I Mangiarua

http://www.w3.org/2001/XMLSchema#string

Haitao Luo

http://www.w3.org/2001/XMLSchema#string

Jamie K Lau

http://www.w3.org/2001/XMLSchema#string

Kathleen C Brown

http://www.w3.org/2001/XMLSchema#string

Nancy A Proper

http://www.w3.org/2001/XMLSchema#string

Piyali Dasgupta

http://www.w3.org/2001/XMLSchema#string

P2860

Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos

Angiogenesis: an organizing principle for drug discovery?

15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Src-mediated Egr-1-dependent rapid induction of FGF-2 expression.

Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?

Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.

ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors

Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin

Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways

Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation.

Nicotinic acetylcholine receptor signaling in tumor growth and metastasis

P2888

s10456-011-9246-9

P304

99-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10456-011-9246-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22198237

http://www.w3.org/2001/XMLSchema#string